Only a handful of the top pharmas have signed Most Favored Nation drug pricing deals with the White House, while smaller ...
Reimbursement policy in the US saw major upheaval in the second half of 2025. New mandates, stalled subsidy negotiations, and pricing pressures created major uncertainty for payers, providers, and ...
Simple and neat solutions are alluring but often wrong. A case in point is President Trump’s proposal to adopt a most favored nation (MFN) policy. The MFN sets Medicaid’s price for a drug at the ...
This transaction, which took place on August 12, 2024, has reinforced MFN Partners LP's position as a major investor in RXO, Inc. The purchase was made directly, as indicated by the filing, and the ...
After the sale, MFN Partners still holds 13,925,000 shares of CNX Resources, maintaining its position as a major stakeholder in the company, which currently has a market capitalization of $4.6 billion ...
Switzerland recently suspended its Most Favoured Nation (MFN) status for India, a move which has the potential to negatively impact Indian investors in IT, pharma and financial sectors as it severely ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Boston-based hedge fund called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback